Prograf-Advagraf Cross Over Conversion Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The present study is aimed at evaluating the impact of a switch from Prograf to Advagraf on renal function, trough tacrolimus levels, drug-related adverse effects and adherence in stable recipients of kidney-pancreas transplants. MPA pharmacokinetics will also be evaluated. The results of this study have the potential to change current practice.
Epistemonikos ID: 48d053bb3692a54e42a55c09bcdc8eb3bbbf0e29
First added on: May 11, 2024